Zanamivir (T2529 in the compound library), the first neuraminidase inhibitor approved for the prevention and treatment of influenza, had the lowest KD values (6.87×10-6) for SOX13 protein (Fig. 9C, Supplementary Fig. 19B). Here, SOX13 is linked to influenza.